Article
Spatial colocalization and combined survival benefit of natural killer and CD8 T cells…
medRxiv · 2024 · Wessel, R. E.; Ageeb, N.; Obeid, J. M.; Mauldin, I.; Goundry, K. A.; Hanson, G. F.; Hossain, M.; Lehman, C.; Gentzler, R. D.; Wages, N. A.; Slingluff, C. L.; Bullock, T. N. J.; Dolatshahi, S.; Brown, M. G.
Key facts
| Title | Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer |
|---|---|
| First author | Wessel, R. E.; Ageeb, N.; Obeid, J. M.; Mauldin, I.; Goundry, K. A.; Hanson, G. F.; Hossain, M.; Lehman, C.; Gentzler, R. D.; Wages, N. A.; Slingluff, C. L.; Bullock, T. N. J.; Dolatshahi, S.; Brown, M. G. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.02.20.581048 |
| Devices mentioned | K042884, K103302 |
| Product codes mentioned | JCC, KPA, MYA, MXZ, NJT, NKF, OOI, PPM, NDS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1